Cargando…
Old versus new antihistamines: Effects on cognition and psychomotor functions
CONTEXT: Antihistamines (AHs) are the most widely long-term therapeutic option to manage allergic diseases. This research aimed to study the effects of long-term administration of AHs: on cognitive (memory, mood, attention, sleep and executive function) and psychomotor performance. MATERIALS AND MET...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810909/ https://www.ncbi.nlm.nih.gov/pubmed/36618177 http://dx.doi.org/10.4103/jfmpc.jfmpc_77_22 |
_version_ | 1784863411241222144 |
---|---|
author | Shamil, K Sheth Prakruti, P Patel Anuradha, M Gandhi Bela, J Shah Chetna, K Desai |
author_facet | Shamil, K Sheth Prakruti, P Patel Anuradha, M Gandhi Bela, J Shah Chetna, K Desai |
author_sort | Shamil, K Sheth |
collection | PubMed |
description | CONTEXT: Antihistamines (AHs) are the most widely long-term therapeutic option to manage allergic diseases. This research aimed to study the effects of long-term administration of AHs: on cognitive (memory, mood, attention, sleep and executive function) and psychomotor performance. MATERIALS AND METHODS: This prospective, observational study for a total duration of 30 months was carried out at the Dermatology OPD in adult patients with dermatological condition who were newly prescribed either chlorpheniramine (4 mg, BD), levocetirizine (10 mg, OD), fexofenadine (180 mg, OD) or bepotastine (10 mg, BD) for at least 28 days as per inclusion and exclusion criteria after taking written informed consent. A detailed history of the patients, memory (using PGI memory scale) and psychomotor functions, Brief Mood Introspection Scale and Epworth Sleepiness Scale were assessed at baseline, 1 week and 4 weeks. Data obtained were analysed using paired sample t-test and one-way ANOVA followed by post hoc analysis (P-value <0.05 statistically significant). RESULTS: A total of 22 in chlorpheniramine group, 23 in levocetirizine group, 20 in fexofenadine group and 18 in bepotastine group were analysed. Chlorpheniramine and levocetirizine had deteriorating effects on cognitive and psychomotor performance, whereas fexofenadine and bepotastine showed positive effect on various cognitive and psychometric tasks. The study results showed chlorpheniramine and levocetirizine to be having sedative effects, whereas fexofenadine was nonsedating. In bepotastine group, no effect on sleep was observed. No significant difference in mood scores was observed in between chlorpheniramine, levocetirizine and fexofenadine groups. In bepotastine group, arousal calm and positive tired scores increased at 4 week as compared to baseline. CONCLUSION: Patients with dermatological illnesses can be prescribed fexofenedine and bepotastine, as compared to chlorpheniramine and levocetirizine, and their cognitive and psychological functions should be evaluated periodically with suitable tests. |
format | Online Article Text |
id | pubmed-9810909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-98109092023-01-05 Old versus new antihistamines: Effects on cognition and psychomotor functions Shamil, K Sheth Prakruti, P Patel Anuradha, M Gandhi Bela, J Shah Chetna, K Desai J Family Med Prim Care Original Article CONTEXT: Antihistamines (AHs) are the most widely long-term therapeutic option to manage allergic diseases. This research aimed to study the effects of long-term administration of AHs: on cognitive (memory, mood, attention, sleep and executive function) and psychomotor performance. MATERIALS AND METHODS: This prospective, observational study for a total duration of 30 months was carried out at the Dermatology OPD in adult patients with dermatological condition who were newly prescribed either chlorpheniramine (4 mg, BD), levocetirizine (10 mg, OD), fexofenadine (180 mg, OD) or bepotastine (10 mg, BD) for at least 28 days as per inclusion and exclusion criteria after taking written informed consent. A detailed history of the patients, memory (using PGI memory scale) and psychomotor functions, Brief Mood Introspection Scale and Epworth Sleepiness Scale were assessed at baseline, 1 week and 4 weeks. Data obtained were analysed using paired sample t-test and one-way ANOVA followed by post hoc analysis (P-value <0.05 statistically significant). RESULTS: A total of 22 in chlorpheniramine group, 23 in levocetirizine group, 20 in fexofenadine group and 18 in bepotastine group were analysed. Chlorpheniramine and levocetirizine had deteriorating effects on cognitive and psychomotor performance, whereas fexofenadine and bepotastine showed positive effect on various cognitive and psychometric tasks. The study results showed chlorpheniramine and levocetirizine to be having sedative effects, whereas fexofenadine was nonsedating. In bepotastine group, no effect on sleep was observed. No significant difference in mood scores was observed in between chlorpheniramine, levocetirizine and fexofenadine groups. In bepotastine group, arousal calm and positive tired scores increased at 4 week as compared to baseline. CONCLUSION: Patients with dermatological illnesses can be prescribed fexofenedine and bepotastine, as compared to chlorpheniramine and levocetirizine, and their cognitive and psychological functions should be evaluated periodically with suitable tests. Wolters Kluwer - Medknow 2022-10 2022-10-31 /pmc/articles/PMC9810909/ /pubmed/36618177 http://dx.doi.org/10.4103/jfmpc.jfmpc_77_22 Text en Copyright: © 2022 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Shamil, K Sheth Prakruti, P Patel Anuradha, M Gandhi Bela, J Shah Chetna, K Desai Old versus new antihistamines: Effects on cognition and psychomotor functions |
title | Old versus new antihistamines: Effects on cognition and psychomotor functions |
title_full | Old versus new antihistamines: Effects on cognition and psychomotor functions |
title_fullStr | Old versus new antihistamines: Effects on cognition and psychomotor functions |
title_full_unstemmed | Old versus new antihistamines: Effects on cognition and psychomotor functions |
title_short | Old versus new antihistamines: Effects on cognition and psychomotor functions |
title_sort | old versus new antihistamines: effects on cognition and psychomotor functions |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810909/ https://www.ncbi.nlm.nih.gov/pubmed/36618177 http://dx.doi.org/10.4103/jfmpc.jfmpc_77_22 |
work_keys_str_mv | AT shamilksheth oldversusnewantihistamineseffectsoncognitionandpsychomotorfunctions AT prakrutippatel oldversusnewantihistamineseffectsoncognitionandpsychomotorfunctions AT anuradhamgandhi oldversusnewantihistamineseffectsoncognitionandpsychomotorfunctions AT belajshah oldversusnewantihistamineseffectsoncognitionandpsychomotorfunctions AT chetnakdesai oldversusnewantihistamineseffectsoncognitionandpsychomotorfunctions |